Altmetric

FOXA1 repression is associated with loss of BRCA1 and increased promoter methylation and chromatin silencing in breast cancer.




COUNTER-compliant statistics provided by IRUS-UK.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.